AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40

Authors: SPARREBOOM A VERWEIJ J VANDERBURG MEL LOOS WJ BROUWER E VIGANO L LOCATELLI A DEVOS AI NOOTER K STOTER G GIANNI L
Citation: A. Sparreboom et al., DISPOSITION OF CREMOPHOR EL IN HUMANS LIMITS THE POTENTIAL FOR MODULATION OF THE MULTIDRUG-RESISTANCE PHENOTYPE IN-VIVO, Clinical cancer research, 4(8), 1998, pp. 1937-1942

Authors: GIANNI L
Citation: L. Gianni, NEW CHALLENGES IN THE MEDICAL-TREATMENT OF BREAST-CANCER, European journal of cancer, 34, 1998, pp. 160-160

Authors: GIANNI L TASSINARI D SARTORI S RINALDI P RAVAIOLI A
Citation: L. Gianni et al., GASTRIC, DUODENAL AND RECTAL MULTIFOCAL MALT LYMPHOMA - THE POSSIBLE COEXISTENCE OF 2 DIFFERENT CELL-POPULATIONS, European journal of cancer, 34(10), 1998, pp. 1640-1641

Authors: GIANNI L CAPRI G VALAGUSSA P BONADONNA G
Citation: L. Gianni et al., PUTTING THE TAXANES TO WORK, European journal of cancer, 34, 1998, pp. 30-30

Authors: PASQUINI E TASSINARI D NICOLINI M GIANNI L OLIVERIO G TONONI A PAPI M DRUDI G PANZINI I RAVAIOLL A
Citation: E. Pasquini et al., GEMCITABINE(GEM) IN ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) OF ELDERLY - A PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 154-154

Authors: GIANNI L
Citation: L. Gianni, COMBINATION THERAPIES WITH TUBULIN INHIBITORS, Annals of oncology, 9, 1998, pp. 56-56

Authors: SPARREBOOM A VERWEIJ J VANDERBURG MEL LOOS WJ VIGANO L LOCATELLI A NOOTER K STOTER G GIANNI L
Citation: A. Sparreboom et al., DISPOSITION OF CREMOPHOR EL IN HUMANS LIMITS THE POTENTIAL FOR MODULATION OF THE MULTIDRUG-RESISTANCE PHENOTYPE IN-VIVO, Annals of oncology, 9, 1998, pp. 551-551

Authors: GIANNI L
Citation: L. Gianni, PACLITAXEL PLUS DOXORUBICIN IN METASTATIC BREAST CA - THE MILAN EXPERIENCE, Oncology, 12(1), 1998, pp. 13-15

Authors: HAWKINS PN APRILE C CAPRIA G VIGANO L MUNZONE E GIANNI L PEPYS MB MERLINI G
Citation: Pn. Hawkins et al., SCINTIGRAPHIC IMAGING AND TURNOVER STUDIES WITH I-131-LABELED SERUM AMYLOID-P COMPONENT IN SYSTEMIC AMYLOIDOSIS, European journal of nuclear medicine, 25(7), 1998, pp. 701-708

Authors: TONONI A PANZINI I OLIVERIO G PASQUINI E GIANNI L NICOLINI M RAVAIOLI A
Citation: A. Tononi et al., VINORELBINE CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - EXPERIENCE IN ELDERLY PATIENTS, Journal of chemotherapy, 9(4), 1997, pp. 304-308

Authors: RAVAIOLI A CANUTI D GIANNI L DESIDERIO F SCARPELLINI M NICOLINI M FAVA C BARTOLINI S MONTI F BERNARDI L POZZUOLI R BARBANTI F MANZO A PIVI P
Citation: A. Ravaioli et al., PROGNOSTIC FACTORS IN HEREDITARY AND SPORADIC BREAST CANCERS - ANALYSIS OF AN ITALIAN SERIES OF 602 PATIENTS, Breast, 6(5), 1997, pp. 275-280

Authors: TASSINARI D SARTORI S FRISONI G NIELSEN I CANGIOTTI C GIANNI L PANZINI I DRUDI G IORIO D
Citation: D. Tassinari et al., CONTINUOUS-INFUSION OF TRAMADOL IN DYING CANCER-PATIENTS - OUR PRELIMINARY DATA, European journal of cancer, 33, 1997, pp. 258-258

Authors: TASSINARI D SARTORI S GIANNI L PASQUINI E RAVAIOLI A
Citation: D. Tassinari et al., IS ACUTE DYSPNEA A RARE SIDE-EFFECT OF VINORELBINE, Annals of oncology, 8(5), 1997, pp. 503-504

Authors: TASSINARI D SARTORI S DRUDI G PANZINI I GIANNI L PASQUINI E ABBASCIANO V RAVAIOLI A IORIO D
Citation: D. Tassinari et al., CARDIAC-ARRHYTHMIAS AFTER CISPLATIN INFUSION - 3 CASE-REPORTS AND A REVIEW OF THE LITERATURE, Annals of oncology, 8(12), 1997, pp. 1263-1267

Authors: LICITRA L CAPRI G FULFARO F GRANDI C TARENZI E CAVINA R GIANNI L
Citation: L. Licitra et al., BIWEEKLY PACLITAXEL AND CISPLATIN IN PATIENTS WITH ADVANCED HEAD AND NECK-CARCINOMA - A PHASE-II TRIAL, Annals of oncology, 8(11), 1997, pp. 1157-1158

Authors: GIANNI L VIGANO L LOCATELLI A CAPRI G GIANI A TARENZI E BONADONNA G
Citation: L. Gianni et al., HUMAN PHARMACOKINETIC CHARACTERIZATION AND IN-VITRO STUDY OF THE INTERACTION BETWEEN DOXORUBICIN AND PACLITAXEL IN PATIENTS WITH BREAST-CANCER, Journal of clinical oncology, 15(5), 1997, pp. 1906-1915

Authors: MOLITERNI A TARENZI E CAPRI G TERENZIANI M BERTUZZI A GRASSELLI G AGRESTI R PIOTTI P GRECO M SALVADORI B PILOTTI S LOMBARDI F VALAGUSSA P BONADONNA G GIANNI L
Citation: A. Moliterni et al., PILOT-STUDY OF PRIMARY CHEMOTHERAPY WITH DOXORUBICIN PLUS PACLITAXEL IN WOMEN WITH LOCALLY ADVANCED OR OPERABLE BREAST-CANCER, Seminars in oncology, 24(5), 1997, pp. 10-14

Authors: FRASSINETI GL ZOLI W SILVESTRO L SERRA P MILANDRI C TIENGHI A GIANNI L GENTILE A SALZANO E AMADORI D
Citation: Gl. Frassineti et al., PACLITAXEL PLUS DOXORUBICIN IN BREAST-CANCER - AN ITALIAN EXPERIENCE, Seminars in oncology, 24(5), 1997, pp. 19-25

Authors: GIANNI L
Citation: L. Gianni, FUTURE-DIRECTIONS OF PACLITAXEL-BASED THERAPY OF BREAST-CANCER, Seminars in oncology, 24(5), 1997, pp. 91-96

Authors: GIANNI L
Citation: L. Gianni, ANTHRACYCLINE RESISTANCE - THE PROBLEM AND ITS CURRENT DEFINITION, Seminars in oncology, 24(4), 1997, pp. 11-17

Authors: GIANNI L CAPRI G
Citation: L. Gianni et G. Capri, EXPERIENCE AT THE ISTITUTO-NAZIONALE-TUMORI WITH PACLITAXEL IN COMBINATION WITH DOXORUBICIN IN WOMEN WITH UNTREATED BREAST-CANCER, Seminars in oncology, 24(1), 1997, pp. 1-3

Authors: GIANNI L
Citation: L. Gianni, PACLITAXEL AND DOXORUBICIN IN METASTATIC BREAST-CANCER - REPLY, Journal of clinical oncology, 14(4), 1996, pp. 1403-1403

Authors: CAPRI G TARENZI E FULFARO F GIANNI L
Citation: G. Capri et al., THE ROLE OF TAXANES IN THE TREATMENT OF BREAST-CANCER, Seminars in oncology, 23(1), 1996, pp. 68-75

Authors: GIANNI L MUNZONE E CAPRI G VILLANI F SPREAFICO C TARENZI E FULFARO F CARACENI A MARTINI C LAFFRANCHI A VALAGUSSA P BONADONNA G
Citation: L. Gianni et al., PACLITAXEL IN METASTATIC BREAST-CANCER - A TRIAL OF 2 DOSES BY A 3-HOUR INFUSION IN PATIENTS WITH DISEASE RECURRENCE AFTER PRIOR THERAPY WITH ANTHRACYCLINES, Journal of the National Cancer Institute, 87(15), 1995, pp. 1169-1175

Authors: GIANNI L FULFARO F TARENZI E MUNZONE E CAPRI G LAFFRANCHI A SPREAFICO C CRABEELS D BONADONNA G
Citation: L. Gianni et al., PACLITAXEL BY 3-H ON DAY 1 AND 8 EVERY 3-WEEKS IN WOMEN WITH ANTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 359-359
Risultati: 1-25 | 26-40